Information Journal Paper
APA:
Copy. (2017). Thymidylate synthase gene variants as predictors of clinical response and toxicity to fluoropyrimidine-based chemotherapy for colorectal cancer. Drug Metabolism and Personalized Therapy, 32(4), 209-218. SID. https://sid.ir/paper/771911/en
Vancouver:
Copy. Thymidylate synthase gene variants as predictors of clinical response and toxicity to fluoropyrimidine-based chemotherapy for colorectal cancer. Drug Metabolism and Personalized Therapy[Internet]. 2017;32(4):209-218. Available from: https://sid.ir/paper/771911/en
IEEE:
Copy, “Thymidylate synthase gene variants as predictors of clinical response and toxicity to fluoropyrimidine-based chemotherapy for colorectal cancer,” Drug Metabolism and Personalized Therapy, vol. 32, no. 4, pp. 209–218, 2017, [Online]. Available: https://sid.ir/paper/771911/en